189 related articles for article (PubMed ID: 24998423)
61. Clinical, microbiological characteristics and predictors of mortality in patients with carbapenemase-producing Enterobacterales bloodstream infections: a multicentre study.
Anton-Vazquez V; Evans TJ; Fernando S; Somasunderam D; David K; Melzer M; Hawkins L; Morris-Jones S; Arias M; Drazho B; Dall'Antonia M; Planche T
Infect Prev Pract; 2023 Sep; 5(3):100298. PubMed ID: 37534297
[TBL] [Abstract][Full Text] [Related]
62. Epidemiology of Carbapenem-Resistant
Lee SH; Kim CH; Lee HY; Park KH; Han SH
Antibiotics (Basel); 2023 Aug; 12(8):. PubMed ID: 37627706
[TBL] [Abstract][Full Text] [Related]
63. [Carbapenem-producing Enterobacteriaceae bloodstream infection: Microbiology's role in their rapid detection].
Alonso Acero L; Gutiérrez Arroyo A; Ramos Ramos JC; Romero Gómez MP
Rev Esp Quimioter; 2019 Dec; 32(6):564-565. PubMed ID: 31648509
[No Abstract] [Full Text] [Related]
64. Acute Encephalopathy in a Patient with Raoultella Ornithinolytica Infection: A Challenging Presentation.
Mader DA; Kerrigan D; Pai J
R I Med J (2013); 2024 Jun; 107(6):7-9. PubMed ID: 38810006
[TBL] [Abstract][Full Text] [Related]
65. Enterobacteriaceae bacteremias among cancer patients: an observational cohort study.
Henao-Martínez AF; González-Fontal GR; Castillo-Mancilla JR; Yang IV
Int J Infect Dis; 2013 Jun; 17(6):e374-8. PubMed ID: 23313157
[TBL] [Abstract][Full Text] [Related]
66. The difficulties of identifying and treating Enterobacterales with OXA-48-like carbapenemases.
Kidd JM; Livermore DM; Nicolau DP
Clin Microbiol Infect; 2020 Apr; 26(4):401-403. PubMed ID: 31899334
[No Abstract] [Full Text] [Related]
67. Rapid separation of very low concentrations of bacteria from blood.
Buchanan CM; Wood RL; Hoj TR; Alizadeh M; Bledsoe CG; Wood ME; McClellan DS; Blanco R; Hickey CL; Ravsten TV; Husseini GA; Robison RA; Pitt WG
J Microbiol Methods; 2017 Aug; 139():48-53. PubMed ID: 28495585
[TBL] [Abstract][Full Text] [Related]
68. The burden of carbapenem-resistant
Tangsawad W; Kositamongkol C; Chongtrakool P; Phisalprapa P; Jitmuang A
Front Pharmacol; 2022; 13():972900. PubMed ID: 36120317
[No Abstract] [Full Text] [Related]
69. Bacteremia in pediatric patients with hematopoietic stem cell transplantation.
Perez P; Patiño J; Estacio M; Pino J; Manzi E; Medina D
Hematol Transfus Cell Ther; 2020; 42(1):5-11. PubMed ID: 31519531
[TBL] [Abstract][Full Text] [Related]
70. The clinical impact of a multiplex real-time PCR system for microbiological diagnosis of sepsis: a mortality study.
Grijalva M; De La Torre K; Sánchez N
New Microbiol; 2020 Apr; 43(2):64-69. PubMed ID: 32310298
[TBL] [Abstract][Full Text] [Related]
71. [Enterobacter cancerogenus bacteremia in a patient with pelvic trauma].
Cruz R; López E; Meneses C; Alegría Y
Rev Chilena Infectol; 2022 Apr; 39(2):218-220. PubMed ID: 35856997
[TBL] [Abstract][Full Text] [Related]
72. Infections Due to Carbapenem-Resistant Bacteria in Patients With Hematologic Malignancies.
Lalaoui R; Javelle E; Bakour S; Ubeda C; Rolain JM
Front Microbiol; 2020; 11():1422. PubMed ID: 32765433
[TBL] [Abstract][Full Text] [Related]
73. Response to Author Comments on "Clinical, microbiological characteristics and predictors of mortality in patients with carbapenemase-producing Enterobacterales blood stream infections".
Anton-Vazquez V; Evans TJ; Fernando S; Somasunderam D; David K; Melzer M; Hawkins L; Morris-Jones S; Arias M; Drazho B; Dall'Antonia M; Planche T
Infect Prev Pract; 2023 Dec; 5(4):100327. PubMed ID: 38107238
[No Abstract] [Full Text] [Related]
74. Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol.
Dickstein Y; Leibovici L; Yahav D; Eliakim-Raz N; Daikos GL; Skiada A; Antoniadou A; Carmeli Y; Nutman A; Levi I; Adler A; Durante-Mangoni E; Andini R; Cavezza G; Mouton JW; Wijma RA; Theuretzbacher U; Friberg LE; Kristoffersson AN; Zusman O; Koppel F; Dishon Benattar Y; Altunin S; Paul M;
BMJ Open; 2016 Apr; 6(4):e009956. PubMed ID: 27098822
[TBL] [Abstract][Full Text] [Related]
75. Notes from the Field: Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases--United States, 2010-2015.
Lyman M; Walters M; Lonsway D; Rasheed K; Limbago B; Kallen A
MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(47):1315-6. PubMed ID: 26633574
[TBL] [Abstract][Full Text] [Related]
76. Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections.
Morrill HJ; Pogue JM; Kaye KS; LaPlante KL
Open Forum Infect Dis; 2015 Apr; 2(2):ofv050. PubMed ID: 26125030
[TBL] [Abstract][Full Text] [Related]
77. Carbapenemase-producing Enterobacteriaceae.
Doi Y; Paterson DL
Semin Respir Crit Care Med; 2015 Feb; 36(1):74-84. PubMed ID: 25643272
[TBL] [Abstract][Full Text] [Related]
78. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors.
Amit S; Mishali H; Kotlovsky T; Schwaber MJ; Carmeli Y
Clin Microbiol Infect; 2015 Jan; 21(1):30-4. PubMed ID: 25636924
[TBL] [Abstract][Full Text] [Related]
79. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
Tamma PD; Goodman KE; Harris AD; Tekle T; Roberts A; Taiwo A; Simner PJ
Clin Infect Dis; 2017 Feb; 64(3):257-264. PubMed ID: 28013264
[TBL] [Abstract][Full Text] [Related]
80. Treatment of KPC-producing Enterobacteriaceae: suboptimal efficacy of polymyxins.
de Oliveira MS; de Assis DB; Freire MP; Boas do Prado GV; Machado AS; Abdala E; Pierrotti LC; Mangini C; Campos L; Caiaffa Filho HH; Levin AS
Clin Microbiol Infect; 2015 Feb; 21(2):179.e1-7. PubMed ID: 25599940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
